SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-24-057167
Filing Date
2024-06-28
Accepted
2024-06-28 16:01:20
Documents
5

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0208719-424b3_clearmind.htm 424B3 162636
2 GRAPHIC image_001.jpg GRAPHIC 13761
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4070
4 GRAPHIC ex99-1_001a.jpg GRAPHIC 2141
5 GRAPHIC ex99-1_001b.jpg GRAPHIC 12669
  Complete submission text file 0001213900-24-057167.txt   209197
Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Filer) CIK: 0001892500 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 424B3 | Act: 33 | File No.: 333-276913 | Film No.: 241085475
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)